Intervention

Lifestyle modification

ClinicalTrials.gov intervention label

Clinical trials24

Recruiting1

Common conditions25

Lead sponsors shown15

Clinical trials

24 shown

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled TrialNCT06138821 · 2025-06-24

The Effect of Lifestyle Modification on the Risk of Prediabetes Among Patients Attending Outpatient Clinic.NCT07462078 · 2024-09-25

An Online Lifestyle Modification Course for People With Multiple SclerosisNCT05374473 · 2022-06-24

Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep ApneaNCT06690723 · 2022-06-08

Nicotinamide Mononucleotide in Hypertensive PatientsNCT04903210 · 2021-06-01

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes MellitusNCT04595968 · 2021-05-21

Evaluation of a Stage-Based Tailored, Nutrition Education Package for Childhood Obesity (ST-NEPCO) (7-12 Years Old)NCT04884451 · 2021-04-03

Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic Patients With Stable coronarY Artery DiseaseNCT04330079 · 2020-05-21

Lifestyle Modification Programme for HIV-infected Individuals With Fatty LiverNCT03913351 · 2019-05-21

3mg Liraglutide for Overweight or ObesityNCT03885297 · 2019-01-18

Multicenter, Randomized, Controlled and Double-blind Study of Efficacy and Safety of Endoscopic Gastric Tubulization in Patients With Non-alcoholic Steatohepatitis (NASH-APOLLO).NCT03426111 · 2018-04-18

The Pre-Diabetes Interventions and Continued Tracking to Ease-out Diabetes (Pre-DICTED) ProgramNCT03503942 · 2017-12-30

Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian AdultsNCT02654665 · 2014-03-01

Effects and Underlying Mechanism of Lipid Lowering Intervention on Vascular Protection in Hypertensive PatientsNCT02254824 · 2013-10-01

Efficacy and Safety of DLBS3233 in Subjects With New Onset of Type 2 Diabetes MellitusNCT01645332 · 2012-07-01

Vikings Fitness Playbook: A Family Based Lifestyle Modification Program for Overweight and Obese YouthNCT01442415 · 2011-10-01

Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study PopulationNCT00964184 · 2009-09-01

Effects of Lifestyle Modification on Metabolic Parameters in Type 2 Diabetic PatientsNCT01051089 · 2009-06-01

Study of Hispanics to Assess Risk Prevention in PrehypertensionNCT01025323 · 2007-12-01

Barriers to Effective Weight Loss in Overweight AdolescentsNCT00562263 · 2007-10-01

Use of Chewing Gum to Facilitate Appetite Control and Weight LossNCT00871676 · 2006-05-01

Effect of Weight Reduction on Inflammatory Markers and Genes Expression in Obese IndividualsNCT00416156 · 2005-05-01

Effects of Physical Activity on Weight Loss and Weight Maintenance in Obese Adults - Three Year Follow-up StudyNCT03861754 · 2004-01-28

Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With PioglitazoneNCT00737347 · 2003-09-01

Common conditions

Leading sponsors

Changi General Hospital1 CHEOL WHAN LEE, M.D., Ph.D1 Chinese Academy of Medical Sciences, Fuwai Hospital1 Chinese University of Hong Kong1 Dexa Medica Group1 Diabetes Foundation, India1 First Affiliated Hospital, Sun Yat-Sen University1 Florida Heart Research Institute1 Inha University Hospital1 Kasr El Aini Hospital1 Neurovalens Ltd.1 Northwestern University1 Pichamol Jirapinyo, MD, MPH1 Puerta de Hierro University Hospital1 Singapore General Hospital1

Trial status mix

COMPLETED12

UNKNOWN8

TERMINATED3

RECRUITING1

Phase mix

NA14

PHASE45

PHASE34

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.